Apyx Medical | SD:专项披露公告
Apyx Medical | 10-Q:季度报表
Apyx Medical | 3:首次持股声明-董事 Vizirgianakis Stavros G.
Apyx Medical | SC 13D/A:超过5%持股股东披露文件(修正)-Stavros G. Vizirgianakis(5.04%)
Apyx Medical | 8-K:Apyx Medical Corporation公布2024年第一季度财务业绩;重申2024年全年财务展望
Apyx Medical | 8-K:重大事件
Apyx Medical | SC 13D:超过5%持股股东披露文件-Archon Capital Management LLC(9.96%),Constantinos Christofilis(9.96%)等
Apyx Medical | SC 13D:超过5%持股股东披露文件-Stavros G. Vizirgianakis(5.04%)
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-AIGH Capital Management, LLC(0%),AIGH Investment Partners, L.L.C.(0%)等
Apyx Medical | 10-K:年度报表
Apyx Medical | 8-K:Apyx Medical Corporation公布2023年第四季度和全年财务业绩;发布2024年全年财务展望
Apyx Medical | 8-K:重大事件
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-Pura Vida Investments, LLC(0.23%),Efrem Kamen(0.23%)
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-Divisadero Street Capital Management, LP(0.0%),William Zolezzi(0.0%)等
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(3.0%),Roderick Wong, M.D.(3.0%)
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-Archon Capital Management LLC(9.96%),Constantinos Christofilis(9.96%)等
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-AIGH Capital Management, LLC(5.9%),Orin H(5.9%)等
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-Cowen Financial Products LLC(0%)
Apyx Medical | SC 13G:超过5%持股股东披露文件-Royce & Associates, LP 52-2343049(6.23%)
Apyx Medical | SC 13G/A:超过5%持股股东披露文件(修正)-Royce & Associates, LP 52-2343049(6.23%)
暂无数据